Abstract
Abstract Background: Ayurveda, traditionally known as “The Science of Life,” has been practiced in India for centuries, focusing on holistic well-being. Despite its longstanding application, Ayurveda has faced challenges in gaining scientific acceptance globally, primarily due to the absence of standardized drug testing and certification. Objective: This study explores the recent initiatives by the Indian government to globalize Ayurveda by integrating modern molecular biology techniques and high-throughput technologies to provide a scientific foundation for Ayurvedic practices. Methods: The research examines the integration of genomics and proteomics with Ayurveda, giving rise to Ayurgenomics and Ayurproteomics. These emerging fields aim to elucidate the molecular mechanisms underlying Ayurvedic practices, leveraging contemporary scientific tools. Results: The interdisciplinary approach seeks to generate evidence-based data for Ayurvedic diagnostics and therapeutics, explore pharmacokinetics and pharmacodynamics, and ensure the safety and efficacy of Ayurvedic medicines. Additionally, the study highlights the need for scientific validation, ethical guidelines, and collaboration between traditional practitioners and modern scientists. Conclusion: Integrating Ayurveda with modern scientific fields like genomics and proteomics has the potential to validate traditional practices and lead to the development of personalized medicine. Overcoming the challenges of scientific validation and promoting collaborative research are key to the success of Ayurgenomics and Ayurproteomics in modern healthcare.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.